An early analysis suggests current vaccines may still be somewhat effective against the new version of the flu ...

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the ...

Flu season is here with a mutated H3N2 strain causing concern. Health experts urge vaccination as holiday gatherings approach ...

A phase 3 trial found a modified mRNA influenza vaccine provided superior protection against influenza like illness in adults ...

The mutated strain, known as subclade K, is causing a surge in cases in the United Kingdom, Canada, and Japan. Here's what to know.

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported.

With flu season beginning in Prince Edward Island, there are some concerns being raised around whether the influenza vaccine ...

Pfizer rises after a study found that the company's new mRNA flu vaccine outperforms traditional shots against predominant strains.